NOS2 and ovarian carcinoma: The researchers found that this combination effectively inhibited the DNA-binding activity of NF-κB in the breast cancer cell line (MDA-MB-231) and ovarian cancer cell line (SKOV3) and subsequently suppressed the expression of downstream genes, including COX-2, MMP-9, and inducible nitric oxide synthase (iNOS).